Skip to content
GenoLensGenoLens

UPB1

Chr 22q11.23

beta-ureidopropionase 1

Aliases:
BUP1
MANE:
ENST00000326010.10

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • beta-ureidopropionase deficiency

    0.79
  • hereditary disease

    0.49
  • acne

    0.30
  • metabolic disease

    0.26
  • Abnormal urine sodium concentration

    0.12
  • hepatocellular carcinoma

    0.07
  • coronary artery disorder

    0.06
  • colorectal cancer

    0.05
  • neoplasm

    0.04
  • hyperinsulinemic hypoglycemia, familial, 4

    0.03

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Beta-ureidopropionase

Catalyzes a late step in pyrimidine degradation (PubMed:22525402, PubMed:24526388). Converts N-carbamoyl-beta-alanine (3-ureidopropanoate) into beta-alanine, ammonia and carbon dioxide (PubMed:10415095, PubMed:10542323, PubMed:11508704, PubMed:22525402, PubMed:24526388, PubMed:29976570). Likewise, converts N-carbamoyl-beta-aminoisobutyrate (3-ureidoisobutyrate) into beta-aminoisobutyrate, ammonia and carbon dioxide (Probable)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.